New Zealand Gazette – 2017 – No. 49

Page 42

✨ Regulatory Notices



NEW ZEALAND GAZETTE, No. 49 — 11 MAY 2017

(preclinical) myxomatous mitral valve disease to delay the onset of clinical symptoms of heart failure, to reduce heart size and increase survival time.

Any person may make a written submission to the director-general concerning this application.

Under sections 16 and 17 of the Act, a written submission:

a. must state in full the reasons for making the submission; and

b. may state any decision sought on that application; and

c. must be received by the director-general no later than 30 working days after the date of notification in the New Zealand Gazette.

Under section 18 of the Act, a copy of every submission will be forwarded to the applicant for the applicant’s information.

The following address is:

a. where submissions on this application are to be sent; and

b. where requests for copies of the public information relating to the application can be sent; and

c. where public information relating to the application can be viewed; and

d. the director-general’s address for service:

ACVM Group, Ministry for Primary Industries, Pastoral House, 25 The Terrace, Wellington 6011. Postal Address: PO Box 2526, Wellington 6140.

The applicant’s address for service is:

Boehringer Ingelheim (NZ) Limited, Level 1, Unit 9, 42 Ormiston Road, Otara, Auckland 2019.

Dated at Wellington this 9th day of May 2017.

MAREE ZINZLEY, Manager Approvals Operations, Ministry for Primary Industries (acting under delegated authority).

2017-go2252

Bail (Drug and Alcohol Testing) Rules 2017

These rules are made under section 73AA of the Bail Act 2000 ("Act") by the Commissioner of Police, who is satisfied that they comply with section 73AAB(2) of that Act.

Notice

  1. Title—These rules are the Bail (Drug and Alcohol Testing) Rules 2017.

  2. Commencement—These rules come into force on (that is to say, at the beginning of) whichever is the later of the following days:

    a. the date or day on which the Bail (Drug and Alcohol Testing) Amendment Act 2016 (under section 2(1)(a) or (b) of that Act) comes into force; and

    b. the day after the date of first publication of the New Zealand Gazette notice by which these rules are made.

  3. Interpretation—(1) In these rules:

    Act means the Bail Act 2000.

    alcohol breath testing procedure means testing carried out by means of a breath screening device or an evidential breath testing device in accordance with paragraph 5.

    breath screening device means each of the following kind of devices:

    a. Dräger 6510;

    b. Dräger 7510NZ.

    defendant means a person who is on bail (other than Police bail) with a drug and alcohol condition.

    evidential breath testing device means each of the following kind of devices:

    a. Dräger 7510NZ;

42



Next Page →



Online Sources for this page:

Gazette.govt.nz — PDF NZ Gazette 2017, No 49




✨ LLM interpretation of page content

🌾 Notice of Application to Vary the Conditions of a Registered Trade Name Product (continued from previous page)

🌾 Primary Industries & Resources
9 May 2017
Trade name variation, Veterinary medicine, Pimobendan, Vetmedin, MPI, Agricultural Compounds and Veterinary Medicines Act 1997
  • Maree Zinzley, Manager Approvals Operations, Ministry for Primary Industries

⚖️ Bail (Drug and Alcohol Testing) Rules 2017

⚖️ Justice & Law Enforcement
Bail, Drug and Alcohol Testing, Rules, Bail Act 2000
  • Commissioner of Police